🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Status
Completed
Location
Human Pharmacology Unit (UFH)
Start Date
2004-11-03
Trial ID
NCT03091868
Treatments Being Tested
The purpose of this study is to show that higher minimum concentration valu...
Status
Completed
Location
NEURO
Start Date
2006-12
Trial ID
NCT00693862
Treatments Being Tested
The main goal of PD research is to develop disease-modifying drugs to delay...
Status
Unknown
Location
Second Affilliated Hospital Zhejiang University
Start Date
2022-01-01
Trial ID
NCT04952194
Treatments Being Tested
This will be a randomised, crossover, double-blind, double-dummy, active-co...
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2016-04-08
Trial ID
NCT02764125
Treatments Being Tested
Phase I open, randomized cross-over pharmacokinetic study....
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2015-08
Trial ID
NCT02554734
Treatments Being Tested
Our primary aim is to compare the change in blood dopamine levels with a si...
Status
Unknown
Location
Ankara Atatürk Sanatorium Training and Research Hospital
Start Date
2023-10-01
Trial ID
NCT06115538
Treatments Being Tested
This is an open, randomised, active-controlled, 2-period crossover study co...
Status
Terminated
Location
Helsinki University Hospital, Department of Neurology
Start Date
2008-01
Trial ID
NCT00562198
Treatments Being Tested
The purpose of the study is to determine if the pharmacokinetic profile of ...
Status
Completed
Location
IRCCS San Raffaele Pisana
Start Date
2006-11
Trial ID
NCT00491998
Treatments Being Tested
To assess motor function and quality of life (QoL) in Parkinson's disease (...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00219284
Treatments Being Tested
The purpose of this study is to confirm that the dose levels and dosing fre...
Status
Completed
Location
Phase I Unit, Orion Pharma
Start Date
2009-12
Trial ID
NCT01070628
Treatments Being Tested